Clinical Trials in Chicago

Showing 16561-16580 of 20,493 trials

Romidepsin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT00062075

This phase II trial is studying how well romidepsin works in treating patients with relapsed or refractory acute myeloid leukemia. Drugs used in chemotherapy, such as romidepsin, work in different ways to stop tumor cells from dividing so they stop growing or die.

Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+5 more

National Cancer Institute (NCI)47 participantsStarted May 2003

Chicago, Illinois, United States • Nashville, Tennessee, United States

COMPLETEDPhase 32.2 miles

Efficacy and Safety of Asenapine in the Prevention of Recurrence of Mood Episodes in Participants With Bipolar 1 Disorder (P06384)

NCT01396291

This study is being done to evaluate the efficacy and safety of asenapine as compared to placebo in preventing the recurrence of mood episodes after stabilization of an acute/manic mixed episode in participants with Bipolar 1 Disorder. After a Screening Period, each participant will receive open-label asenapine and matching placebo for 12 to 16 weeks. Participants who meet stabilization criteria may then be randomized into one of the two study arms (asenapine or matching placebo) to receive double-blind treatment for up to an additional 26-weeks.

Bipolar 1 Disorder

Forest Laboratories561 participantsStarted Dec 2011

Anaheim, California, United States • Chino, California, United States • Escondido, California, United States +77 more locations

Romidepsin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Efficacy and Safety of Asenapine in the Prevention of Recurrence of Mood Episodes in Participants With Bipolar 1 Disorder (P06384)

Find Trials by Condition in Chicago

Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed-dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF

Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Vaccine Therapy Compared With Interferon Alfa in Treating Patients With Stage III Melanoma

Improving Mood and Behavior in Assisted Living Residents Through Skills Training for Their Caregivers

Study of Asthma and Nasal Steroids

Efficacy and Safety of Ultratrace™ Iobenguane I 131 in Neuroblastoma

TachoSil® Versus Surgicel® Original for the Secondary Treatment of Local Bleeding in Adult and Pediatric Patients Undergoing Hepatic Resection Surgery

Trial of Autologous, Hapten-Modified Vaccine, OVAX, in Patients With Relapsed Stage III or IV Ovarian Cancer

Efficacy Study of Auriclosene Irrigation Solution on Urinary Catheter Patency

Study to Compare the Effect of Ipilimumab Retreatment With That of Chemotherapy in Advanced Melanoma

Multi-center Evaluation of the VERSANT® CT/GC DNA 1.0 Assay (kPCR)in Detecting C. Trachomatis and N. Gonorrhoeae

Clinical Trial Of Neoadjuvant Chemotherapy (NAC)In Upper Tract Urothelial Carcinoma (UTUC)

Repair of Infected or Contaminated Hernias

REASON 1 Trial: Sonography in Cardiac Arrest

Patient-Defined Treatment Success and Preferences in Stage IV Lung Cancer Patients

Randomized Controlled Trial of Tailored Interactive Multimedia to Reduce Colorectal Cancer Screening Disparities

A Study to Evaluate the Efficacy and Safety of TMC207 in Patients With Pulmonary Infection With Multi-drug Resistant Mycobacterium Tuberculosis